Publication|Articles|July 8, 2024
Supplements and Featured Publications
- Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Advertisement
This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
2
5 Things to Know as Flu Season Begins
3
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
4
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
5




































